正电子发射断层扫描能否有助于对肥厚型心肌病患者的心源性猝死风险进行分层？ - Suppr

Suppr

超能文献

Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?

作者信息

Kay G Neal

机构信息

Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

J Nucl Cardiol. 2019 Aug;26(4):1135-1137. doi: 10.1007/s12350-018-1299-3. Epub 2018 May 14.

DOI:10.1007/s12350-018-1299-3

PMID:29761308

Abstract

摘要

相似文献

Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?

J Nucl Cardiol. 2019 Aug;26(4):1135-1137. doi: 10.1007/s12350-018-1299-3. Epub 2018 May 14.

Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Heart Fail Rev. 2019 Jul;24(4):439-459. doi: 10.1007/s10741-019-09775-4.

[Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death].

Arq Bras Cardiol. 2010 Apr;94(4):535-40. doi: 10.1590/s0066-782x2010005000017. Epub 2010 Mar 26.

CT characterization of myocardial substrate in hypertrophic cardiomyopathy.

J Cardiovasc Comput Tomogr. 2014 Mar-Apr;8(2):166-9. doi: 10.1016/j.jcct.2013.12.019. Epub 2014 Jan 11.

Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.

Am J Cardiol. 2018 May 1;121(9):1081-1089. doi: 10.1016/j.amjcard.2018.01.022. Epub 2018 Feb 6.

Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.

Curr Opin Cardiol. 1995 Jan;10(1):9-15. doi: 10.1097/00001573-199501000-00003.

Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.

Circ Cardiovasc Imaging. 2017 Aug;10(8). doi: 10.1161/CIRCIMAGING.117.006446.

Hypertrophic Cardiomyopathy as a Cause of Sudden Cardiac Death in the Young: A Meta-Analysis.

Am J Med. 2016 May;129(5):486-496.e2. doi: 10.1016/j.amjmed.2015.12.027. Epub 2016 Jan 20.

Partial myocardial fibrosis in hypertrophic cardiomyopathy demonstrated by 18F-fluoro-deoxyglucose positron emission tomography and multislice computed tomography.

Int J Cardiol. 2006 Feb 15;107(2):284-6. doi: 10.1016/j.ijcard.2005.01.069.

Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.

Cardiovasc Diabetol. 2020 May 13;19(1):64. doi: 10.1186/s12933-020-01036-1.

引用本文的文献

PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis.

Diagnostics (Basel). 2025 Jan 8;15(2):133. doi: 10.3390/diagnostics15020133.

Positron emission tomography (O-water, C-acetate, C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Int J Cardiol Heart Vasc. 2019 Dec 20;26:100452. doi: 10.1016/j.ijcha.2019.100452. eCollection 2020 Feb.

本文引用的文献

Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?

J Nucl Cardiol. 2019 Aug;26(4):1125-1134. doi: 10.1007/s12350-018-1298-4. Epub 2018 May 14.

Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.

JAMA Cardiol. 2018 Jun 1;3(6):520-525. doi: 10.1001/jamacardio.2018.0789.

B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.

Heart Rhythm. 2018 Oct;15(10):1484-1490. doi: 10.1016/j.hrthm.2018.04.030. Epub 2018 Apr 28.

Risk stratification in hypertrophic cardiomyopathy.

Herz. 2020 Feb;45(1):50-64. doi: 10.1007/s00059-018-4700-8. Epub 2018 Apr 25.

Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.

Am J Cardiol. 2018 May 1;121(9):1081-1089. doi: 10.1016/j.amjcard.2018.01.022. Epub 2018 Feb 6.

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.

Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

J Am Coll Cardiol. 2018 Oct 2;72(14):1677-1749. doi: 10.1016/j.jacc.2017.10.053. Epub 2017 Oct 30.

Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2413-2422. doi: 10.1007/s00259-016-3465-7. Epub 2016 Aug 16.

Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.

Pacing Clin Electrophysiol. 2016 Jul;39(7):642-51. doi: 10.1111/pace.12861. Epub 2016 May 4.

Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

Heart Rhythm. 2016 May;13(5):1155-1165. doi: 10.1016/j.hrthm.2015.12.048. Epub 2016 Jan 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验